ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 34, which means every article in Journal of Addiction Research & Therapy has got 34 average citations.

Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016

Total published articles

88 88 61 59 24 28 24 59 48

Research, Review articles and Editorials

20 68 49 7 8 18 0 0 0

Research communications, Review communications, Editorial communications, Case reports and Commentary

68 0 1 15 3 1 0 0 0

Conference proceedings

0 11 5 0 0 0 85 56 105

Citations received as per Google Scholar, other indexing platforms and portals

90 168 573 612 590 545 567 473 440
Journal total citations count 4859
Journal impact factor 9.79
Journal 5 years impact factor 14.65
Journal cite score 13.41
Journal h-index 34
Journal h-index since 2019 26
image

O'Neill N (2014) Mephedrone and multiplicity: User accounts of effects and harms. Contemporary Drug Problems 41: 417-443.

  View at Publisher | View at Google Scholar
image

de Sousa Fernandes Perna EB, Papaseit E, Pérez-Mañá C, Mateus J, Theunissen EL, et al. (2016) Neurocognitive performance following acute mephedrone administration, with and without alcohol. Journal of Psychopharmacology 30: 1305-1312.

  View at Publisher | View at Google Scholar
image

Ben Mosbah H. " I was like a rose, now I look like a thorn" An exploratory study of women injecting drug users (WIDU) in Tunisia.

  View at Publisher | View at Google Scholar
image

Beijer U, Scheffel Birath C, DeMartinis V, af Klinteberg B (2015) Facets of male violence against women with substance abuse problems: women with a residence and homeless women. Journal of interpersonal violence: 0886260515618211.

  View at Publisher | View at Google Scholar
image

Dufort M, Stenbacka M, Gumpert CH (2015) Physical domestic violence exposure is highly associated with suicidal attempts in both women and men. Results from the national public health survey in Sweden. The European Journal of Public Health 25: 413-418.

  View at Publisher | View at Google Scholar
image

Blum K, Febo M, D Badgaiyan R, R Braverman E, Dushaj K, et al. (2016) Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. Current Pharmaceutical Design 22: 5837-5854.

  View at Publisher | View at Google Scholar
image

Blum K, Febo M, Fried L, Li M, Dushaj K, et al. (2017) Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS). Substance Use & Misuse 52: 535-547.

  View at Publisher | View at Google Scholar
image

Blum K, Gold M, Clark HW, Dushaj K, Badgaiyan RD (2016) Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?. Substance use & misuse 51: 1674-1679.

  View at Publisher | View at Google Scholar
image

Blum K, Oscar-Berman M, Blum SH, Madigan MA, Waite RL, et al. (2014) Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?. Journal of alcoholism and drug dependence: 2.

  View at Publisher | View at Google Scholar
image

Elian AA, Hackett J (2015) Urine analysis of buprenorphine/norbuprenorphine/naloxone in drugs and driving cases. J Appl Bioanal 1: 80-88.

  View at Publisher | View at Google Scholar
image

Blum K, Han D, Giordano J, Lohmann R, Braverman ER, et al. (2013) Neurogenetics and Nutrigenomics of Reward Deficiency Syndrome (RDS): Stratification of Addiction Risk and Mesolimbic Nutrigenomic Manipulation of Hypodopaminergic Function. InOmics for Personalized Medicine: 365-398.

  View at Publisher | View at Google Scholar
image

Badgaiyan RD, Sinha S, Blum K (2015) Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?. Journal of reward deficiency syndrome 1.

  View at Publisher | View at Google Scholar
image

Tzatzarakis MN, Vakonaki E, Kovatsi L, Belivanis S, Mantsi M, et al. (2015) Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy. Journal of analytical toxicology 39: 313-320.

  View at Publisher | View at Google Scholar
image

McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, et al. (2015) Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: Role of enhanced brain reward functional connectivity and homeostasis redeeming joy. Journal of behavioral addictions 4: 106-115.

  View at Publisher | View at Google Scholar
image

Blum K, Oscar-Berman M, Jacobs W, McLaughlin T, Gold MS (2014) Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?. Journal of addiction research & therapy 5.

  View at Publisher | View at Google Scholar
image

Ahmadi J (2016) Psychiatric Disorders Induced By Abuse Of Non-addictive Substances: An Original Finding. Annals of Behavioural Science.

  View at Publisher | View at Google Scholar
image

Ahmadi J (2016) Misuse of Zolpidem to get high: A distinguished mystery. Neuropsychiatry 6.

  View at Publisher | View at Google Scholar
image

Ahmadi J, Oji B (2016) Quick Opium Detoxification With 100 mg of Buprenorphine. J Neurol Neurosci 7:5.

  View at Publisher | View at Google Scholar
image

Ahmadi J (2016) Alcohol and Drug Use at the US-Mexico Border–Does Cross-Border Mobility make a Difference. J Drug Abuse 2: 1.

  View at Publisher | View at Google Scholar
image

Ahmadi J. Alcohol Withdrawal Craving Treatment with Low Dose of Buprenorphine: A New Experience.

  View at Publisher | View at Google Scholar
Peer Reviewed Journals

Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri and Aquaculture Journals

Dr. Krish

agriaquaculture@omicsonline.com

+1-702-714-7001Extn: 9040

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

chemistryjournals@omicsonline.com

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

clinicaljournals@omicsonline.com

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjournals@omicsonline.com

1-702-714-7001Extn: 9042

General Science

Andrea Jason

generalscience@omicsonline.com

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

geneticsmolbio@omicsonline.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immunomicrobiol@omicsonline.com

1-702-714-7001Extn: 9014

Nursing & Health Care Journals

Stephanie Skinner

nursinghealthcare@omicsonline.com

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

medicaljournals@omicsonline.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuropsychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

pharmajournals@omicsonline.com

1-702-714-7001Extn: 9007

 
© 2008- 2024 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version